Insider Transactions in Q3 2022 at Roivant Sciences Ltd. (ROIV)
Insider Transaction List (Q3 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 23
2022
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
17,392
-1.61%
|
$52,176
$3.07 P/Share
|
Sep 23
2022
|
Rakhi Kumar Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,741
-1.22%
|
$5,223
$3.07 P/Share
|
Sep 23
2022
|
Matthew Gline CEO |
SELL
Open market or private sale
|
Direct |
21,053
-1.75%
|
$63,159
$3.07 P/Share
|
Sep 15
2022
|
Ilan Oren |
BUY
Grant, award, or other acquisition
|
Direct |
52,142
+48.5%
|
-
|
Sep 15
2022
|
James C Momtazee |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+48.11%
|
-
|
Sep 15
2022
|
Keith S Manchester |
BUY
Grant, award, or other acquisition
|
Direct |
52,142
+50.0%
|
-
|
Sep 15
2022
|
Andrew Lo |
BUY
Grant, award, or other acquisition
|
Direct |
52,142
+50.0%
|
-
|
Sep 15
2022
|
Daniel Allen Gold |
BUY
Grant, award, or other acquisition
|
Direct |
52,142
+50.0%
|
-
|
Aug 24
2022
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
16,530
-1.5%
|
$49,590
$3.71 P/Share
|
Aug 24
2022
|
Rakhi Kumar Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,652
-1.14%
|
$4,956
$3.71 P/Share
|
Aug 24
2022
|
Matthew Gline CEO |
SELL
Open market or private sale
|
Direct |
20,009
-1.63%
|
$60,027
$3.71 P/Share
|
Jul 25
2022
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
16,896
-1.51%
|
$67,584
$4.33 P/Share
|
Jul 25
2022
|
Rakhi Kumar Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,686
-1.15%
|
$6,744
$4.33 P/Share
|
Jul 25
2022
|
Matthew Gline CEO |
SELL
Open market or private sale
|
Direct |
20,455
-1.64%
|
$81,820
$4.33 P/Share
|
Jul 20
2022
|
Ilan Oren |
BUY
Grant, award, or other acquisition
|
Direct |
3,223
+50.0%
|
-
|
Jul 20
2022
|
James C Momtazee |
BUY
Grant, award, or other acquisition
|
Direct |
3,923
+50.0%
|
-
|